Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christine L. Kempton

HLA-DRB1–factor VIII Binding Is a Risk Factor for Inhibitor Development in Nonsevere Hemophilia: A Case-Control Study

English

Related publications

In Non-Severe Hemophilia a the Risk of Inhibitor After Intensive Factor Treatment Is Greater in Older Patients: A Case-Control Study

Journal of Thrombosis and Haemostasis

English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research

English

Product Type and the Risk of Inhibitor Development in Nonsevere Haemophilia a Patients: A Case-Control Study

British Journal of Haematology

English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)

English

244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A

Molecular Therapy

Molecular Medicine

Molecular Biology

English

Is Iron Deficiency Anaemia a Risk Factor for Febrile Seizure? A Case Control Study

International Journal of Contemporary Pediatrics

English

A Case Report of Acquired Hemophilia Due to the Inhibitor Against Coagulation Factor VIII After Esophagectomy for Esophageal Cancer

Japanese Journal of Gastroenterological Surgery

Gastroenterology

English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis

English

Smoking Is a Risk Factor for Anti-CCP Antibodies Only in Rheumatoid Arthritis Patients Who Carry HLA-DRB1 Shared Epitope Alleles

Annals of the Rheumatic Diseases

Molecular Biology

English